This agreement follows a longstanding partnership between Navamedic and Vitaflo International, dating back to 2005.

Vitaflo International's medical nutrition products make up Navamedic's IEM (inborn error of metabolism) products and are part of the Hospital segment.

'We are thrilled to have renewed the contract with Vitaflo International, which underpins the strength of Navamedic's marketing and distribution channels in the Nordics. The medical nutrition product portfolio represents one of Navamedic's key product offerings to our customers in the Nordics, and we look forward to continuing our collaboration and partnership with Vitaflo International,' commented Kathrine Gamborg Andreassen, CEO of Navamedic.

Contact:

Kathrine Gamborg Andreassen

Tel: +47 951 78 680

Email: kathrine@navamedic.com

Lars Hjarrand

Tel: +47 917 62 842

Email: lars.hjarrand@navamedic.com

About Navamedic

Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange.

(C) 2023 Electronic News Publishing, source ENP Newswire